Imetelstat Shows Potential to Transform QOL in Lower-Risk MD

Sunil Iyer, MD, expands on the potential role of imetelstat for select patients with lower-risk myelodysplastic syndrome.

Related Keywords

New York , United States , Sunil Iyer , Oncologic Drugs Advisory Committee , Meeting Of The Oncologic Drugs Advisory Committee , Columbia University Irving Medical Center , International Prognostic Scoring System , Drugs Advisory Committee , Science Summit , New York City , D , Mds , Lower Risk Myelodysplastic Syndrome , Imetelstat , Phase 2 3 Imerge Mds3001 Trial Nct02598661 ,